510(k) device
Solitaire X Revascularization Device
Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (POL, Class II) · First FDA decision Mar 1, 2021, newest Mar 1, 2021Acute ischemic stroke
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
1
Naming "Solitaire X Revascularization"
MAUDE reports
4
Brand "Solitaire X Revascularization", since 2015
PubMed studies
0
Mentioning "Solitaire X Revascularization"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Solitaire X Revascularization Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K203358 · Decided Mar 1, 2021 · 105 days after receipt
Device type: Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (POL) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Solitaire X Revascularization", any status and sponsor, newest update first.
- Endovascular Therapy for Large Core Patients With Uncertain Response to ThrombectomyEnrolling by invitation
Stanford UniversityAcademic, hospital or other
NCT06961487 · 50 participants (planned) · Start Jul 26, 2024 · Primary completion May 2028
Device: Endovascular thrombectomy with any FDA-approved device · For: Stroke, Acute; Ischemic Stroke, Acute
Sites: Palo Alto, California
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Solitaire X Revascularization", and for the whole product code for context.
This brand
4 reports: 3 malfunction, 1 injury, 0 death
Whole product code POL
97 reports: 40 malfunction, 55 injury, 2 death
Newest reports for this brand
MEDTRONIC / MICRO THERAPEUTICS, INC. DBA EV3 NEUROVASCULAR
MW5178395 · Received Oct 31, 2025 · Event dated Oct 21, 2025
Device type: Catheter, Thrombus Retriever (NRY)
Device problem as coded: Break; Difficult to Remove; Material Twisted/Bent
Patient problem as coded: Foreign Body In Patient
- SOLITAIRE X REVASCULARIZATION DEVICEMalfunction
MICRO THERAPEUTICS, INC. DBA EV3
2029214-2020-00444 · Received May 11, 2020 · Event dated May 7, 2020
Device type: Catheter, Thrombus Retriever (NRY)
Device problem as coded: Break; Physical Resistance/Sticking
Patient problem as coded: No Known Impact Or Consequence To Patient
MICRO THERAPEUTIC INC/ MEDTRONIC INC.
MW5092657 · Received Jan 30, 2020 · Event dated Jan 20, 2020
Device type: Neurovascular Mechanical Thrombectomy Device For Acute Ischemic Stroke Treatment (POL)
Device problem as coded: Material Separation
Patient problem as coded: No Known Impact Or Consequence To Patient
1 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Solitaire X Revascularization"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code POL.
- Trevo NXT ProVue RetrieverStryker Neurovascular · 510(k) 2023
- Trevo NXT ProVue RetrieverStryker · 510(k) 2020
- Solitaire 2 Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 510(k) 2019
- pRESET Delta Thrombectomy Device and pRESET Delta LITE Thrombectomy DevicePhenox Limited · 510(k) 2025
- pRESET LITE Thrombectomy DevicePhenox Limited · 510(k) 2023
- pRESET Thrombectomy DevicePhenox Limited · 510(k) 2023
- Trevo XP ProVue Retriever and Trevo NXT ProVue RetrieverStryker Neurovascular · 510(k) 2020
- Solitaire Platinum Revascularization DeviceMicro Therapeutics, Inc. d/b/a ev3 Neurovascular · 510(k) 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.